In vivo 2D J-resolved magnetic resonance spectroscopy of rat brain with a 3-T clinical human scanner

[1]  N R Jagannathan,et al.  Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)‐induced experimental demyelinating lesion model , 2002, NMR in biomedicine.

[2]  P G Webb,et al.  Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.

[3]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[4]  W Dreher,et al.  On the use of two‐dimensional‐J NMR measurements for in Vivo proton MRS: Measurement of homonuclear decoupled spectra without the need for short echo times , 1995, Magnetic resonance in medicine.

[5]  D M Spielman,et al.  Spatially resolved two‐dimensional spectroscopy , 1999, Magnetic resonance in medicine.

[6]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[7]  K. Nicolay,et al.  Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study. , 1999, Journal of neurosurgery.

[8]  D. Leibfritz,et al.  Fast echo planar based correlation‐peak imaging: Demonstration on the rat brain in vivo , 2000, Magnetic resonance in medicine.

[9]  J A Sorenson,et al.  Localized 2D J‐resolved H MR spectroscopy of human brain tumors in vivo , 1996, Journal of magnetic resonance imaging : JMRI.

[10]  J. Kurhanewicz,et al.  Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer , 2000, Magnetic resonance in medicine.

[11]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[12]  O. Petroff,et al.  Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. , 1995, Magnetic resonance imaging.

[13]  W Dreher,et al.  Detection of homonuclear decoupled in vivo proton NMR spectra using constant time chemical shift encoding: CT-PRESS. , 1999, Magnetic resonance imaging.

[14]  N Sailasuta,et al.  Proton spectroscopy without water suppression: The oversampled J‐resolved experiment , 1998, Magnetic resonance in medicine.

[15]  S. Nelson,et al.  3T Brain Spectroscopy: Repeatability and Inter-subject Variability , 2003 .

[16]  M. Rovaris,et al.  A longitudinal study comparing the sensitivity of CSE and RARE sequences in detecting new multiple sclerosis lesions. , 1999, Magnetic resonance imaging.

[17]  M. Samii,et al.  Long-time in-vivo metabolic monitoring following experimental brain contusion using proton magnetic resonance spectroscopy. , 2002, Acta neurochirurgica. Supplement.

[18]  D Matthaei,et al.  1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.

[19]  R. Price,et al.  In vivo and in vitro proton NMR spectroscopic studies of thiamine‐deficient rat brains , 2001, Journal of magnetic resonance imaging : JMRI.

[20]  Thomas Wisniewski,et al.  Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.

[21]  M. Samii,et al.  1H-MR spectroscopic monitoring of posttraumatic metabolism following controlled cortical impact injury: pilot study. , 2000, Acta neurochirurgica. Supplement.

[22]  D. Leibfritz,et al.  Fast U‐FLARE‐based correlation‐peak imaging with complete effective homonuclear decoupling , 2003, Magnetic resonance in medicine.

[23]  R. Dijkhuizen,et al.  T1 and T2 relaxation times of the major 1H‐containing metabolites in rat brain after focal ischemia , 1995, NMR in biomedicine.